News | Global Survey: Nearly Half of Women Under 40 With Advanced Breast Cancer Are Raising Young Children, Facing Pressures Beyond the Disease Itself
Results from the first global survey of survival and quality of life among young patients with advanced breast cancer were announced today at the 8th International Consensus Conference for Advanced Breast Cancer (ABC8). Project 528, a global study launched by the Young Survival Coalition (YSC), offers the first detailed view of the overlapping challenges young women face while living with advanced breast cancer. The combined pressures of parenting, finances, mental health, and health care systems can turn survival into a long and isolating struggle.
YSC CEO Jennifer Merschdorf said at the conference: “We launched Project 528 to address a longstanding gap: the voices of young people with advanced breast cancer have rarely been truly heard in clinical research and policy discussions. We now finally have the first global dataset that makes their lived experiences visible and allows future research, services, and policy to be based on their actual needs rather than assumptions.”
Survey data reveal the survival challenges facing young mothers
The survey included 3,881 women with breast cancer from 67 countries, including 385 patients under age 40 with advanced disease. Nearly half (48%) of these young patients were raising children under 18, while their financial and social circumstances deteriorated sharply after diagnosis:
64% said they had to stop working or lost a source of income;
40% had medical debt;
The proportion feeling financially secure fell from 51% before diagnosis to just 3% after treatment.
Regarding psychological and social support, 80% reported severe distress, including concerns about body image, sexual health, and fertility. Most said their doctors had never proactively asked about these issues. Practical challenges involving childcare, housework, and transportation were also widespread, yet effective social support was lacking.
Major gap in early diagnosis: 85% detect problems themselves
Only 14% of patients were diagnosed through clinical screening or routine examinations; the other 85% received a diagnosis only after noticing an abnormality themselves. Although 84% felt able to ask questions at diagnosis, 40% still delayed seeking care. The main reasons were primary care clinicians overlooking symptoms, limited awareness of breast cancer risk, or fear that led patients to avoid evaluation.
Merschdorf said: “Young patients are almost entirely overlooked by early screening systems. They often have to advocate more forcefully to ensure their concerns are taken seriously.”
Serious inequities remain in precision testing and treatment information
Although 90% of respondents had germline genetic testing to identify inherited cancer-associated variants, only 59% received tumor genomic testing, limiting their understanding of the cancer's molecular characteristics and recurrence risk.
Regarding treatment knowledge, 77% understood the reasons for their treatment, but one-quarter remained confused, and only 46% were offered more than one treatment option.
Most concerning, targeted therapy was the least understood area, with only a small proportion of patients clearly understanding how it works and when it is indicated.
Online patient communities became an important source of information and emotional support for many young women, but only 43% were referred to them by their health care teams.
Merschdorf concluded: “This analysis reveals a consistent theme: medicine may be advancing, but care in the real world remains highly fragmented. Young patients are forced to advocate for themselves amid exhaustion, fear, and financial collapse. This is a systemic imbalance.”
Experts call for precision medicine to reach every patient
Professor Fatima Cardoso, oncologist and president of the ABC Global Alliance, said: “This is the first global view of the real lives of young patients with advanced breast cancer. It is concerning that some patients are still not offered essential germline and tumor genomic testing. In the era of precision medicine, this gap is unacceptable. We hope policymakers use these findings to close systemic gaps in diagnosis, treatment, and social support.”
Advanced breast cancer (ABC) remains incurable, although appropriate treatment can significantly slow progression and extend survival. Systematic global statistics on incidence and survival among young women are still lacking.
“I want to teach my children that even when life is unfair, we must not stop loving it”
Christina Thammasen of California is one of the people behind the report. Diagnosed at age 38, she has now lived with metastatic breast cancer for seven years. As a counselor, she actively participates in online peer-support groups.
Christina said: “My life felt split in two by the diagnosis. I worked to rebuild my identity, not simply as a ‘survivor,’ but as someone who values every moment of life. I want my children to understand that life will not always be fair, but we must keep moving forward and keep loving.”
Merschdorf concluded: “Project 528 is more than a survey; it is a roadmap. It shows us where young people with breast cancer face the greatest challenges and how future research, services, and policies should be redesigned to respond to their actual lives.”
News | Global Survey: Nearly Half of Women Under 40 With Advanced Breast Cancer Are Raising Young Children, Facing Pressures Beyond the Disease Itself
News | Global Survey: Nearly Half of Women Under 40 With Advanced Breast Cancer Are Raising Young Children, Facing Pressures Beyond the Disease Itself
Results from the first global survey of survival and quality of life among young patients with advanced breast cancer were announced today at the 8th International Consensus Conference for Advanced Breast Cancer (ABC8). Project 528, a global study launched by the Young Survival Coalition (YSC), offers the first detailed view of the overlapping challenges young women face while living with advanced breast cancer. The combined pressures of parenting, finances, mental health, and health care systems can turn survival into a long and isolating struggle.
YSC CEO Jennifer Merschdorf said at the conference: “We launched Project 528 to address a longstanding gap: the voices of young people with advanced breast cancer have rarely been truly heard in clinical research and policy discussions. We now finally have the first global dataset that makes their lived experiences visible and allows future research, services, and policy to be based on their actual needs rather than assumptions.”
Survey data reveal the survival challenges facing young mothers
The survey included 3,881 women with breast cancer from 67 countries, including 385 patients under age 40 with advanced disease. Nearly half (48%) of these young patients were raising children under 18, while their financial and social circumstances deteriorated sharply after diagnosis:
64% said they had to stop working or lost a source of income;
40% had medical debt;
The proportion feeling financially secure fell from 51% before diagnosis to just 3% after treatment.
Regarding psychological and social support, 80% reported severe distress, including concerns about body image, sexual health, and fertility. Most said their doctors had never proactively asked about these issues. Practical challenges involving childcare, housework, and transportation were also widespread, yet effective social support was lacking.
Major gap in early diagnosis: 85% detect problems themselves
Only 14% of patients were diagnosed through clinical screening or routine examinations; the other 85% received a diagnosis only after noticing an abnormality themselves. Although 84% felt able to ask questions at diagnosis, 40% still delayed seeking care. The main reasons were primary care clinicians overlooking symptoms, limited awareness of breast cancer risk, or fear that led patients to avoid evaluation.
Merschdorf said: “Young patients are almost entirely overlooked by early screening systems. They often have to advocate more forcefully to ensure their concerns are taken seriously.”
Serious inequities remain in precision testing and treatment information
Although 90% of respondents had germline genetic testing to identify inherited cancer-associated variants, only 59% received tumor genomic testing, limiting their understanding of the cancer's molecular characteristics and recurrence risk.
Regarding treatment knowledge, 77% understood the reasons for their treatment, but one-quarter remained confused, and only 46% were offered more than one treatment option.
Most concerning, targeted therapy was the least understood area, with only a small proportion of patients clearly understanding how it works and when it is indicated.
Online patient communities became an important source of information and emotional support for many young women, but only 43% were referred to them by their health care teams.
Merschdorf concluded: “This analysis reveals a consistent theme: medicine may be advancing, but care in the real world remains highly fragmented. Young patients are forced to advocate for themselves amid exhaustion, fear, and financial collapse. This is a systemic imbalance.”
Experts call for precision medicine to reach every patient
Professor Fatima Cardoso, oncologist and president of the ABC Global Alliance, said: “This is the first global view of the real lives of young patients with advanced breast cancer. It is concerning that some patients are still not offered essential germline and tumor genomic testing. In the era of precision medicine, this gap is unacceptable. We hope policymakers use these findings to close systemic gaps in diagnosis, treatment, and social support.”
Advanced breast cancer (ABC) remains incurable, although appropriate treatment can significantly slow progression and extend survival. Systematic global statistics on incidence and survival among young women are still lacking.
“I want to teach my children that even when life is unfair, we must not stop loving it”
Christina Thammasen of California is one of the people behind the report. Diagnosed at age 38, she has now lived with metastatic breast cancer for seven years. As a counselor, she actively participates in online peer-support groups.
Christina said: “My life felt split in two by the diagnosis. I worked to rebuild my identity, not simply as a ‘survivor,’ but as someone who values every moment of life. I want my children to understand that life will not always be fair, but we must keep moving forward and keep loving.”
Merschdorf concluded: “Project 528 is more than a survey; it is a roadmap. It shows us where young people with breast cancer face the greatest challenges and how future research, services, and policies should be redesigned to respond to their actual lives.”
Story source:
Collected online